They work by mimicking the behavior of Glucagon-Like Peptide 1, a naturally occurring hormone that triggers the pancreas to release insulin, slow digestion and reduce appetite and hunger
Blood Sugar Shifts: GLP-1 supports smooth insulin release
GLP-1 analogues have completely changed this bleak therapeutic picture
Patients should not assume that all semaglutide products are interchangeable
Abstract Background Glucagon-like peptide-1 (GLP-1) plays a crucial role in metabolic disorders by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, thereby improving glycemic control
Obesity is a growing threat to public health, increasing risks of numerous diseases and mortality, and impairing quality of life